OX40-enhanced tumor rejection and effector T cell differentiation decreases with age.

Ruby, Carl E

OX40-enhanced tumor rejection and effector T cell differentiation decreases with age. [electronic resource] - Journal of immunology (Baltimore, Md. : 1950) Feb 2009 - 1481-9 p. digital

Publication Type: Comparative Study; Journal Article

1550-6606

10.4049/jimmunol.182.3.1481 doi


Aging--immunology
Animals
Antibodies--administration & dosage
CD4-Positive T-Lymphocytes--immunology
Cell Differentiation--immunology
Cell Line, Tumor
Colonic Neoplasms--immunology
Female
Graft Rejection--immunology
Inflammation Mediators--administration & dosage
Interleukin-12--administration & dosage
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C57BL
Mice, Transgenic
Receptors, OX40--antagonists & inhibitors
Sarcoma, Experimental--immunology